Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 3,644 | 1,399 | 13,696 | 0 | 0 |
| Gross Profit | 3,644 | 1,399 | 13,696 | N/A | N/A |
| Operating Expenses | 24,086 | 21,692 | 20,401 | 18,209 | 22,776 |
| Operating Income | -20,442 | -20,293 | -6,705 | -18,209 | -22,776 |
| Other Income | 19 | 12 | -33 | -9 | 62 |
| Pre-tax Income | -20,423 | -20,281 | -6,738 | -18,218 | -22,714 |
| Income Tax | 23 | 26 | 92 | N/A | N/A |
| Net Income Continuous | -20,446 | -20,307 | -6,830 | -18,218 | -22,714 |
| Net Income | $-20,446 | $-20,307 | $-6,830 | $-18,218 | $-22,714 |
| EPS Basic Total Ops | -7.77 | -7.75 | -2.50 | -7.00 | -6.50 |
| EPS Basic Continuous Ops | -7.76 | -7.72 | -2.60 | -6.94 | -6.39 |
| EPS Diluted Total Ops | -7.77 | -7.75 | -2.50 | -7.00 | -6.50 |
| EPS Diluted Continuous Ops | -7.76 | -7.72 | -2.60 | -6.94 | -6.39 |
| EBITDA(a) | $-19,548 | $-19,732 | $-6,147 | $-17,673 | $-22,287 |